1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Kimberly Lyman conducted an unannounced complaint visit to initiate an investigation into the above allegation. LPA was greeted and granted entry into the facility and explained the reason for the visit.
During the course of the visit, LPA toured the facility and interviewed staff as well as reviewed and obtained pertinent documentation such as medication orders and medication administration record. Regarding the allegation that staff are not adequately providing supervision to a resident while in care, the investigation revealed the following: During the tour of the facility, LPA observed five caregivers, one med tech and Health Services Director on-site during the visit. Facility schedule indicates the same staffing level for second shift as well. Health Services Director works Sunday-Thursday, 8-5 PM. Licensing regulations do not require a nurse to be on-site at licensed facilities. Resident 1 (R1) admitted into Hospice care on 08/02/2023. Resident is prescribed Olanzapine 2.5 MG, generic for Zyprexa as of 08/03/2023. Hospice notes indicate resident was prescribed Zyprexa for behaviors as resident is diagnosed with Advanced Dementia. Once medication administration for Olanzapine started, CONTINUED ON LIC 9099C DATED 08/10/2023 |